NEW YORK, June 23, 2021 (GLOBE NEWSWIRE) --
If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:
Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com
Kindred Biosciences, Inc. (NASDAQ: KIN)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Kindred Biosciences, Inc. (NASDAQ: KIN) in connection with the proposed acquisition of the company by Elanco Animal Health Incorporated (NYSE: ELAN). Under the terms of the merger agreement, the company’s shareholders will receive $9.25 per share in cash for each share of KIN common stock that they hold. If you own KIN shares and wish to discuss this investigation or your rights, please call us or visit our website: http://www.weisslawllp.com/kin/
First Midwest Bancorp, Inc. (NASDAQ: FMBI)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of First Midwest Bancorp, Inc. (NASDAQ: FMBI) in connection with the proposed acquisition of the company by Old National Bancorp (“Old National”). Pursuant to the merger agreement, FMBI shareholders will receive 1.1336 shares of Old National common stock for each FMBI share that they own, representing implied per-share merger consideration of approximately $20.44 based upon Old National’s June 22, 2021 closing price of $18.03. If you own FMBI shares and wish to discuss this investigation or your rights, please call us or visit our website: http://www.weisslawllp.com/fmbi/
Select Bancorp, Inc. (NASDAQ: SLCT)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Select Bancorp, Inc. (NASDAQ: SLCT) in connection with the proposed acquisition of the company by First Bancorp. Pursuant to the merger agreement, SLCT shareholders will receive 0.408 shares of First Bancorp common stock for each SLCT share that they own, representing implied per-share merger consideration of approximately $17.58 based upon First Bancorp’s June 22, 2021 closing price of $43.09. If you own SLCT shares and wish to discuss this investigation or your rights, please call us or visit our website: https://weisslawllp.com/slct/
Constellation Pharmaceuticals, Inc. (NASDAQ: CNST)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Constellation Pharmaceuticals, Inc. (NASDAQ: CNST) in connection with the proposed acquisition of the company by MorphoSys AG. The transaction is structured as an all-cash tender offer pursuant to which the company’s shareholders will receive $34.00 for each share of CNST common stock that they hold. If you own CNST shares and wish to discuss this investigation or your rights, please call us or visit our website: https://weisslawllp.com/cnst/